Insides from Breast Cancer researcher Dr Luca Magnani from Imperial College London, UK. EpiPredict PhD fellow Simone Borgoni, from the German Cancer Research Centre, DKFZ, DE, interviewed Dr Magnani and wrote a blog for Medium.
We are honored to announce the conference ‘Systems Epigenetics: Towards Precision Cancer Medicine’ that we organize in Amsterdam, the Netherlands on 27-30 November 2018.
In this video Daniel Vilar Jorge explains why we study epigenetics in the resistance to endocrine therapy in breast cancer. It was first publicly presented during our first Science Café organized at DKFZ, Heidelberg, 2017.
Read our next blog in Medium by EpiPredict fellow Maryam Soleimani Dodaran (UvA, NL). She explains her role in the EpiPredict international research effort as data scientist.
EpiPredict fellows pitched their research and answered the excellent questions by the (ex-) patients and their representatives.
The EpiPredict consortium comes together at Hammersmith campus, Imperial College London, 9-15 December 2017. It includes communication/entrepreneurial training, project meeting, ICL research sessions and the Imperial Science Cafe at the Maggie's Centre.
The EpiPredict award for best presentation during the ICL project meeting went to Emre Sofyali (ESR6, DKFZ, Heidelberg).
Two EpiPredict early stage researchers on epigenetics. Stefania Astrologo (ESR1, UvA, NL) and Désirée Goubert (ESR8, UMCG, NL) wrote together their second blog with EpiPredict outreach partner Science Matter on the online publishing platform Medium.
You are warmly invited to attend the free UvA-SILS-EpiPredict mini-symposium, held in Amsterdam, Wednesday 15 November 2017.
EpiPredict's Prof. Dr Marianne Rots (UMCG , NL) was interviewed for the feature story of August 2017 in Nature Medicine.
Two EpiPredict early stage researchers on epigenetics. Stefania Astrologo (ESR1, UvA, NL) and Désirée Goubert (ESR8, UMCG, NL) wrote together with EpiPredict outreach partner Biotecture a blog in the online publishing platform Medium.
On World Cancer Day, Italian cancer researcher Dr Luca Magnani tells us about how close European collaboration helped bring about a recent discovery.
An international team of researchers, including EpiPredict researchers, discovered a mechanism that makes a common type of breast cancer cells resistant to a specific form of hormone treatment. This was published online in Nature Genetics, 23 Jan 2017.
The EpiPredict award for best presentation during the DKFZ project meeting went to Stefania Astrologo (ESR1, University of Amsterdam)
Will Beckman (ESR3, UvA) together with EpiPredict Partner Organisation Biotecture wrote a blog in Medium, ‘From Lab bench to Bed, How understanding epigenetics could benefit breast cancer patients’.
We are recruiting for a: PhD fellowship or Early Stage Researcher position Biotechnology and Bioengineering/Synthetic Biology
Breaking article in www.epibeat.com by researchers of Imperial College London: “Intragenic methylation: searching for biomarker needles in the epigenetic haystack”.
Dr Perry Moerland, co-supervisor in EpiPredict, publishes in BMC Medical Genomics. The article titled Breast cancer subtype predictors revisited: from consensus to concordance?
The EpiPredict supervisors Lilia Alberghina, Daniela Gaglio, Pernette Verschure and Hans V. Westerhoff are speakers at the SYSBIO-EPIGEN joint workshop, hosted by Prof. Lilia Alberghina: Epigenetics & Systems Biology, at the University of Milano-Bicocca.
Visit our Facebook and Twitter accounts to view and interact about our latests stories
All EpiPredict early stage research positions have been filled
The EpiPredict kick-off meeting in Amsterdam, The Netherlands, 6 March 2015, was a great success.
Open public programme ‘Beyond the Walls‘ at VondelCS during the TEDx Amsterdam talk, ‘Epigenetics makes us tick’ given by Dr Pernette Verschure.
Dr Pernette Verschure, coordinator of the EpiPredict consortium, was interviewed by the Amsterdam FM radio station on 30 September 2014, 17:00.
The grant preparation phase will start